Esther Rajavelu - Chief Executive Officer, Chief Financial Officer and Chief Business Officer at Spero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Issuer Symbol
SPRO on Nasdaq
All Insider Reports
All Insider Reports

Esther Rajavelu - trading volume in the past year for Spero Therapeutics, Inc.

Holdings reported by Esther Rajavelu for Spero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,012,091 $2,388,534 $2.36 06 Feb 2026 Direct
Stock Option (Right to Buy) 498,000 02 Feb 2026 Direct Common Stock

Transactions reported by Esther Rajavelu for Spero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.